Ischemic stroke is a complex cerebrovascular disorder characterized by highly unpredictable outcomes influenced by ...

Cellular death within the infarcted core occurs rapidly due to energy depletion, resulting in the release of DAMPs such as ...

Synthekine has reported positive initial data from a Phase Ia/Ib trial evaluating STK-012 in first-line, programmed ...

O'Connell and Doherty emphasized that the decision to advance EBD candidates will be data-driven in early 2026.

In a world that chases fitness and wellness amidst the hustle of daily lives, weight loss jabs have become the magic pills ...

Updated MDNA11 Clinical Data from the ABILITY-1 Study will be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology ...

PRISM BioLab, Co. Ltd. ("PRISM") announces that today, PRISM and Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka; President and COO: Toichi Takino; hereinafter "Ono") have achieved the initial ...

Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...